Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

wsj.com - Nikkei Rises 1.0%, Led by Pharma, Machinery Stocks
Nikkei Rises 1.0%, Led by Pharma, Machinery Stocks
Wall Street Journal

0015 GMT — Japanese stocks are higher, supported by bargain-hunting, as recent rising momentum in crude oil eases. Pharmaceutical and machinery stocks are leading gains. Eisai is up 2.4% and is 3.2% higher. The dollar is at 155.87 yen, up…

ndtv.com - Abhishek Sureshkumar Awasthi - Exclusive: After Survey Flags 2,800% Pharma Profit, Tukaram Mundhe Calls For Transparency
Exclusive: After Survey Flags 2,800% Pharma Profit, Tukaram Mundhe Calls For Transparency
NDTV

'Basically there has to be a fair trade, fair margin of profit.,' Tukaram Mundhe said. Summary is AI-generated, newsroom-reviewed Maharashtra FDA found up to 2800% profit margin on IV sets sold to hospitals and consumers Maharashtra FDA wrote to…

seekingalpha.com - Petri Dish Reports - SOPHiA Genetics: Scaling Phase Begins As U.S. And Pharma Monetisation Inflect (SOPH)
SOPHiA Genetics: Scaling Phase Begins As U.S. And Pharma Monetisation Inflect (SOPH)
Seeking Alpha

SOPHiA GENETICS SA is entering a scale-and-monetize phase, with its genomic intelligence platform validated and execution now the main focus. U.S. adoption, liquid biopsy expansion, and early biopharma/CDx commercialization—highlighted by…

seekingalpha.com - SA Transcripts - Zealand Pharma A/S (ZLDPY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Zealand Pharma A/S (ZLDPY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha

Zealand Pharma A/S (ZLDPY) Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 11:30 AM EDT Adam Steensberg - President & CEO Cool. Well, thank you all for being here. I'm James Machin from the Morgan Stanley banking team and…

newswire.ca - Piramal Pharma Solutions Advances Sustainability Efforts with Solar Power Plant Addition at Morpeth, UK Site
Piramal Pharma Solutions Advances Sustainability Efforts with Solar Power Plant Addition at Morpeth, UK Site
CNW

Piramal Pharma Solutions is installing a ground-mounted solar power plant (4.3 MWp) at its integrated drug substance and drug product site in Morpeth, UK. The new plant will provide renewable energy directly to the site through a behind-the-meter…

thehill.com - The HIll Staff - Watch live: Trump's pick for surgeon general faces Senate confirmation hearing
Watch live: Trump's pick for surgeon general faces Senate confirmation hearing
The Hill

Dr. Nicole Saphier, whom President Trump tapped to serve as U.S. surgeon general, will testify before the Senate Health, Education, Labor and Pensions Committee on Wednesday morning. Saphier, a media personality, was the third person Trump picked…

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Receives Average Recommendation of 'Moderate Buy' from Analysts
Urogen Pharma (NASDAQ:URGN) Receives Average Recommendation of 'Moderate Buy' from Analysts
MarketBeat

Urogen Pharma (NASDAQ:URGN - Get Free Report) has earned a consensus rating of 'Moderate Buy' from the ten research firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has issued…

marketbeat.com - Baird Financial Group Inc. Buys New Position in Ascendis Pharma A/S $ASND
Baird Financial Group Inc. Buys New Position in Ascendis Pharma A/S $ASND
MarketBeat

Baird Financial Group Inc. purchased a new position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The…

globenewswire.com - Bavarian Nordic A/S - Tarja Stenvall Appointed Chief Executive Officer of Bavarian Nordic
Tarja Stenvall Appointed Chief Executive Officer of Bavarian Nordic
GlobeNewswire

COPENHAGEN, Denmark, September 17, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that Tarja Stenvall has been appointed President and Chief Executive Officer, effective October 15, 2026, succeeding Paul Chaplin whose departure was…

fool.com - Adria Cimino - This Trend is Excellent News for Eli Lilly and Its Investors
This Trend is Excellent News for Eli Lilly and Its Investors
The Motley Fool

Eli Lilly (LLY +0.15%) is the global leader in one of the hottest growth markets on the planet: the weight loss drug market. The pharma giant holds 60% of the U.S. market, while its closest rival, Novo Nordisk (NVO -1.93%), has about 38% share.

thestandard.com.hk - The Standard 英文虎報 - Cathay Pacific, HK Express carry a record of more than 3.6 million passengers in Aug
Cathay Pacific, HK Express carry a record of more than 3.6 million passengers in Aug
The Standard

Cathay Pacific and budget airline HK Express carried a record number of over 3.6 million passengers in August despite elevated jet fuel prices, driven by robust travel demand during the summer peak. SCROLL TO CONTINUE WITH CONTENT Flagship carrier…

newstatesman.com - Freddie Hayward - Donald Trump's last hurrah
Donald Trump's last hurrah
The Newstatesman

Donald Trump wanted us to share in a collective delusion. On stage at the Republican convention in Dallas, Texas, looking out at a mass of empty seats, he was telling us that they were full. He could see the empty seats. We could see the empty…

seekingalpha.com - Albert Anthony - Alkami Technology: A Modest Growth Idea Among Tech Stocks Serving Digital Banking (ALKT)
Alkami Technology: A Modest Growth Idea Among Tech Stocks Serving Digital Banking (ALKT)
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

seekingalpha.com - Edmund Ingham - Novo Nordisk: Why This Corporate Rebrand Is More Than Simply PR Posturing (NYSE:NVO)
Novo Nordisk: Why This Corporate Rebrand Is More Than Simply PR Posturing (NYSE:NVO)
Seeking Alpha

Novo Nordisk A/S has rebranded as 'Novo' with a new strategy, aiming for greater consumer focus and operational agility amid intensifying GLP-1 competition. NVO's GLP-1 franchise faces mounting pressure from Eli Lilly's superior market share and…

fastcompany.com - Hunter Schwarz - Does Novo Nordisk's slimmed down rebrand signal a new era of DTC revivalism?
Does Novo Nordisk's slimmed down rebrand signal a new era of DTC revivalism?
Fast Company

Novo Nordisk, the Dandish drugmaker behind the weight-loss drugs Ozempic and Wegovy, announced it's rebranding to “Novo” beginning this week. It's part of a larger trend in healthcare branding. The rise of telehealth…

Receive a Daily briefing on Pharma Industry News

Get Started